Ramadan fasting and cardiac biomarkers in patients with multiple cardiovascular disease risk factors

Internet Journal of Cardiovascular Research

Volumn 7, Issue 2, 2011, Pages

  Ibrahim, O ^a   Kamaruddin, N A ^a   Wahab, N A ^a   Rahman, M M ^a  

^a DEPARTMENT OF PHARMACOLOGY   (Malaysia)

Author keywords

Cardiovascular biomarkers; HbAlc; HDL; High sensitive c reactive protein; LDC

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; GLUCOSE; HEMOGLOBIN A1C; LIPID; PLASMINOGEN ACTIVATOR INHIBITOR 1; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BIOCHEMISTRY; BLOOD GLUCOSE MONITORING; BLOOD PRESSURE MEASUREMENT; BODY MASS; BODY WEIGHT; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL ASSESSMENT; CONTROLLED STUDY; DIABETES MELLITUS; DIET RESTRICTION; DISEASE MARKER; DYSLIPIDEMIA; FAMILY HISTORY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PROSPECTIVE STUDY; RISK FACTOR; SMOKING;

EID: 79960947100     PISSN: None     EISSN: 15402592     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Mohamed Ali, Gaman CN, Katanec Diana. Fasing of Person with Diabetes Mellitus during Ramadan. Diabetologia Croatica. 2002; 31-32
2. Fazel, M. Medical implication of controlled fasting. Journal of the Royal Society of Medicine. 1998;91:260-263.
3. HallakMH NM. Body weight loss and changes in blood lipid levels in normal men on hypocaloric diets during Ramadan fasting. The American Journal of Clinical Nutrition. 1988;48:1197-1210.
4. Adlouni A GN, Benslimane, A, Lecert JM, Saile R. Fasting during Ramadan induces a marked increase in high-density lipoprotein cholesterol and decrease in low-density lipoprotein cholesterol. Annals of Nutrition and Metabolism. 1997;41:242-149.
5. Maislos M A-RY, Zuili l. Gorging and plasma HDL-cholesterol--the Ramadan model. European Journal of Clinical Nutrition. 1988;52(2):127-130.
6. Maislos M KN, Assali. Marked increase in plasma high-density lipoprotein cholesterol after prolonged fasting during Ramadan. American Journal Clinical Nutrition. 1993;57:640-642.
7. Mafauzy M MWB, Anum M.Y. A study of fasting diabetic patients during the month of Ramadan. Medical Journal of Malaysia. 1990;45:14-17.
8. Mustafa CD, Gursoy A. A comparison of glycemic effects of glimepiride, repaglinide and insulin glargine in type 2 diabetes mellitus during Ramadan fasting. Daibetes Research and Clinical Practice. 2007;75:141-47.
9. Gumaa KA MK, Mahmoud NA, Gader AM. The effect of fasting in Ramadan: Serum uric acid and lipid concentration. British Journal of Nutrition. 1978;40:573-581.
10. Al Suwaidi J BA, Suliman A, Hajar R, Salam AM, Numan MT, Al Binali HA. A population based study of Ramadan fasting and acute coronary syndromes. Heart. 2004;90:695-696.
11. Bener A HA, Fares A, Al-Sayed HM, Al-Suwaidi J. Is there any effect of Ramadan fasting on stroke incidence? Singapore Medical Journal. 2006;47:404-408.
12. Al Suwaidi J BA, Hajar HA, Numan MT. Does hospitalization for congestive heart failure occur more frequently in Ramadan? A population-based study (1991-2001). International Journal of Cardiology. 2004;96:217-221.
13. MoH Malaysia, editor. Clinical Practical Guideline on Management of Obesity; 2003.
14. Friedewald WI LR, Frederickson DS. Wstimation of the concentration of low density lipoprotein cholestrol in plasma, without use of the preparative ultracentrifuge. Clinical Chemistry. 1972;18:499-502.
15. Okrainec Karen M, Banerjee K Devi. Coronary artery disease in the developing world. American Heart Journal. 2004;148:7-15.
16. Ridker, PM. High sensitivity C-Reactive protein: Potential Adjunct for Global Risk Assessment in the Primary Prevention of Cardiovascular Disease. Circulation. 2001;103(13); 1813-1818.
17. Eth Yeh JW. Coming of age of C-reactive protein: using inflammation markers in cardiology. Circulation. 2003;107:370-372.
18. Fehime A. Interleukin-6, C-reactive protein and Biochemical parameters during prolonged intermittent fasting. Annals of Nutrition and Metabolism. 2007;51;88-95.
19. Roman Huber MN, Nicole Basler. Effects of subtotal fasting on plasmatic coagulation, fibrinolyti status and platelet activation: A controlled pilot study in healthy subjects. Nutrition, Metabolism and Cardiovascular Disease. 2005;15.212-218.
20. Hackam DG AS. Emerging risk factors for atherosclerotic vascular disease: a critical review of the evidence. JAMA. 2003;290:932-940.
21. Lindmark Eva W, Seigbahn. Blood Cell Activation, Coagulation and Inflammation in Men and Women with coronary artery disease. Thrombosis Research. 2001;3;249-259.
22. Ridker P. Clinical Application of C - reactive protein for Cardiovascular Disease Detection and Prevention. Circulation. 28 January 2003;107(3),363-369.
23. Ridker, M Paul MEJ. C-Reactive Protein, the Metabolic Syndrome, and Risk of Incident Cardiovascular Events. Circulation. 2003;107:391-397.
24. Gupta A, Badyal KD. Effect of atorvastain on hs-CRP in acute coronary syndrome. British Journal of Clinical Pharmacology. 2008;66;411-413.
25. Ridker PM D, Fonseca E. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. NEJM. 2008;359:2195.
26. Mussoni L, MannucciL. Hypertriglyceridemia and regulation of fibrinolytic activity. Arterioscler Thromb. 1992;12:19.
27. Kamal, M. Study the effects of Ramadan fasting on the serum Glucose and Lipid profile among Healthy Jordanian Students. American journal of Applied Science. 2007;8:565-569.
28. Heilbronn LK NM, Clifton PM,. Energy restriction and weight loss on very low fat diets reduce C-reactive protein concenteration in obese healthy women. Arterioscler Thromb Vasc Biol. 2001;21: 968-970.
29. Saleh Salhamoud ES, Cherian Boby. Effect of Ramadan fasting on waist circumference, blood pressure, lipid profile and blood sugar on a sample of healthy Kuwaiti men and women. Mal J Nutr. 2005;11:143-150
30. Benaji BNM, Roky R. Diabetes and Ramadan: Review of the literature. Daibetes Research and Clinical Practice. 2006;73:117-125.
31. Sulimani R LM, Al-Atlas O. The effect of Ramadan fasting on diabetes control in type 2 diabetic patients. Nutrition Research. 1991;11:261-264
32. Salti Ibrahim BE, Detournay Bruno. A. Popolation-Based Study of Diabetes and its characteristics during the fasting month of Ramadan in 13 countries (EPIDIAR) study. Diabetes Care. 2004;27: 2306-2317.
33. Perk G GJ, Aamar S. The effect of the fast of Ramadan on ambulatory blood pressure in treated hypertensives. Journal of Human Hypertension. 2001;15;723-725.